Gryphon Financial Partners’s BioLife Solutions BLFS Stock Holding History

Gryphon Financial Partners’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$347K	Buy	12,273 +274	+2%	+$6.4K	0.03%	283
2026 Q1	$229K	Hold	11,999	–	–	0.02%	331
2025 Q4	$290K	Hold	11,999	–	–	0.03%	278
2025 Q3	$306K	Hold	11,999	–	–	0.03%	255
2025 Q2	$258K	Hold	11,999	–	–	0.03%	265
2025 Q1	$274K	Hold	11,999	–	–	0.04%	233
2024 Q4	$311K	Hold	11,999	–	–	0.04%	198
2024 Q3	$300K	Hold	11,999	–	–	0.04%	226
2024 Q2	$257K	Hold	11,999	–	–	0.04%	239
2024 Q1	$223K	Hold	11,999	–	–	0.04%	240
2023 Q4	$195K	Hold	11,999	–	–	0.03%	228
2023 Q3	$166K	Buy	11,999 +141	+1%	+$2.22K	0.04%	185
2023 Q2	$262K	Sell	11,858 -55	-0.5%	-$1.16K	0.06%	160
2023 Q1	$259K	Hold	11,913	–	–	0.06%	164
2022 Q4	$217K	Buy	11,913 +74	+0.6%	+$1.53K	0.05%	181
2022 Q3	$269K	Hold	11,839	–	–	0.07%	159
2022 Q2	$164K	Buy	11,839 +20	+0.2%	+$293	0.04%	185
2022 Q1	$269K	Buy	11,819 +170	+1%	+$4.48K	0.05%	165
2021 Q4	$434K	Buy	11,649 +4,627	+66%	+$199K	0.08%	137
2021 Q3	$297K	Buy	+7,022	New	+$338K	0.07%	154

Other funds holding BLFS

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Gryphon Financial Partners's BLFS Position: Q2 2026 in Review

Gryphon Financial Partners increased its BioLife Solutions (BLFS) stake by 2.3% in Q2 2026, buying an estimated $6.4K and bringing the position to 12,273 shares worth $347K. The position accounts for 0.03% of the portfolio, ranked #283.

Gryphon Financial Partners first reported a position in BLFS in Q3 2021 and has held it in 20 quarters since. The position peaked at $434K in Q4 2021. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

Gryphon Financial Partners held 12,273 shares of BioLife Solutions worth $347K as of Q2 2026.
Gryphon Financial Partners bought 274 BioLife Solutions shares in Q2 2026, an estimated $6.4K.
BioLife Solutions made up 0.03% of Gryphon Financial Partners's portfolio in Q2 2026, its #283 holding.
Gryphon Financial Partners first reported a position in BioLife Solutions in Q3 2021 and has held it in 20 quarters since.
Gryphon Financial Partners's BioLife Solutions position peaked at $434K in Q4 2021.
216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Gryphon Financial Partners's 13F filing for Q2 2026, filed 5 Aug 2026.